Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8533049
Reference Type
Journal Article
Title
Potentially reversible acute cerebellar toxicity associated with Minnelide
Author(s)
Khanipour Roshan, S; Spano, AD; Mckinney, AM; Nascene, DR; ,
Year
2017
Is Peer Reviewed?
1
Journal
Neuroradiology
ISSN:
0028-3940
EISSN:
1432-1920
Publisher
Springer Verlag
Volume
59
Issue
4
Page Numbers
419-421
Language
English
PMID
28303374
DOI
10.1007/s00234-017-1809-z
Abstract
Minnelide is an experimental antineoplastic agent that is currently the subject of a phase 1 clinical trial for the treatment of pancreatic and gastrointestinal malignancies. In this study, we documented two cases of reversible acute cerebellar toxicity (REACT) associated with Minnelide and compared its radiological manifestations with other cerebellotoxic agents.
Keywords
Cerebellar cortex; Cerebellar toxicity; Diffusion weighted imaging; Minnelide; Reversible acute cerebellar toxicity
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity